SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-14-005473
Filing Date
2014-11-12
Accepted
2014-11-12 07:30:38
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q fprx-10q_20140930.htm 10-Q 1420482
2 EX-31.1 fprx-ex311_201409308.htm EX-31.1 7748
3 EX-31.2 fprx-ex312_201409309.htm EX-31.2 7766
4 EX-32.1 fprx-ex321_20140930269.htm EX-32.1 5159
5 EX-32.2 fprx-ex322_20140930270.htm EX-32.2 5090
  Complete submission text file 0001564590-14-005473.txt   5911512

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT fprx-20140930.xml EX-101.INS 1041988
7 XBRL TAXONOMY EXTENSION SCHEMA fprx-20140930.xsd EX-101.SCH 27906
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fprx-20140930_cal.xml EX-101.CAL 34238
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fprx-20140930_def.xml EX-101.DEF 57345
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE fprx-20140930_lab.xml EX-101.LAB 206208
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fprx-20140930_pre.xml EX-101.PRE 144003
Mailing Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080
Business Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS INC (Filer) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36070 | Film No.: 141211076
SIC: 2834 Pharmaceutical Preparations